Ze‐Hong Miao

5.5k total citations
136 papers, 4.3k citations indexed

About

Ze‐Hong Miao is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Ze‐Hong Miao has authored 136 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Molecular Biology, 41 papers in Oncology and 22 papers in Organic Chemistry. Recurrent topics in Ze‐Hong Miao's work include Cancer therapeutics and mechanisms (32 papers), DNA Repair Mechanisms (22 papers) and Bioactive Compounds and Antitumor Agents (22 papers). Ze‐Hong Miao is often cited by papers focused on Cancer therapeutics and mechanisms (32 papers), DNA Repair Mechanisms (22 papers) and Bioactive Compounds and Antitumor Agents (22 papers). Ze‐Hong Miao collaborates with scholars based in China, United States and Italy. Ze‐Hong Miao's co-authors include Jian Ding, Ying-Qing Wang, Yves Pommier, Yuanchao Li, Zhaoli Zhou, Xia‐Juan Huan, Yaxi Yang, Chunhao Yang, Keli Agama and Liping Lin and has published in prestigious journals such as Journal of Biological Chemistry, Bioinformatics and Biomaterials.

In The Last Decade

Ze‐Hong Miao

134 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ze‐Hong Miao China 37 2.7k 968 888 488 485 136 4.3k
Maciej Czerwiński United States 15 1.9k 0.7× 1.1k 1.1× 898 1.0× 467 1.0× 92 0.2× 22 4.1k
Shiow‐Lin Pan Taiwan 37 2.2k 0.8× 634 0.7× 894 1.0× 565 1.2× 132 0.3× 148 3.8k
Michael C. Alley United States 28 2.6k 0.9× 1.3k 1.3× 1.3k 1.5× 643 1.3× 118 0.2× 48 5.2k
Yongkui Jing China 41 4.2k 1.5× 572 0.6× 790 0.9× 659 1.4× 160 0.3× 140 5.7k
Zhi Shi China 42 2.4k 0.9× 1.6k 1.6× 305 0.3× 363 0.7× 219 0.5× 122 4.3k
Curtis Hose United States 22 2.3k 0.9× 1.2k 1.2× 1.6k 1.8× 511 1.0× 111 0.2× 31 4.7k
Jiang‐Jiang Qin China 42 3.9k 1.4× 1.8k 1.8× 394 0.4× 335 0.7× 170 0.4× 175 5.8k
Betty J. Abbott United States 15 2.3k 0.8× 1.2k 1.2× 1.2k 1.3× 578 1.2× 145 0.3× 19 4.7k
Chunlin Zhuang China 33 2.4k 0.9× 519 0.5× 1.7k 2.0× 519 1.1× 101 0.2× 159 4.7k
Chakrabhavi Dhananjaya Mohan India 38 1.7k 0.6× 794 0.8× 1.1k 1.2× 366 0.8× 157 0.3× 100 3.7k

Countries citing papers authored by Ze‐Hong Miao

Since Specialization
Citations

This map shows the geographic impact of Ze‐Hong Miao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ze‐Hong Miao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ze‐Hong Miao more than expected).

Fields of papers citing papers by Ze‐Hong Miao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ze‐Hong Miao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ze‐Hong Miao. The network helps show where Ze‐Hong Miao may publish in the future.

Co-authorship network of co-authors of Ze‐Hong Miao

This figure shows the co-authorship network connecting the top 25 collaborators of Ze‐Hong Miao. A scholar is included among the top collaborators of Ze‐Hong Miao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ze‐Hong Miao. Ze‐Hong Miao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sun, Yuting, Jiaqi Yuan, Shanshan Song, et al.. (2023). YCH1899, a Highly Effective Phthalazin-1(2H)-one Derivative That Overcomes Resistance to Prior PARP Inhibitors. Journal of Medicinal Chemistry. 66(17). 12284–12303. 8 indexed citations
3.
Su, Ailing, Changqing Tian, Xubin Bao, et al.. (2023). Proteasome inhibitors reduce CD73 expression partly via decreasing p-ERK in NSCLC cells. Life Sciences. 332. 122129–122129. 2 indexed citations
4.
Sun, Lin, Qian Wu, Xia‐Juan Huan, et al.. (2022). Loss of VOPP1 Contributes to BET Inhibitor Acquired Resistance in Non–Small Cell Lung Cancer Cells. Molecular Cancer Research. 20(12). 1785–1798. 1 indexed citations
5.
Yin, Fangzhou, Xia‐Juan Huan, I Wayan Mudianta, et al.. (2020). Polyoxygenated Cembranoids from Soft Coral Lobophytum Crassum and Their Anti‐tumoral Activities. Chinese Journal of Chemistry. 39(3). 640–646. 13 indexed citations
6.
Wu, Qihao, Wenting Chen, Song‐Wei Li, et al.. (2019). Cytotoxic Nitrogenous Terpenoids from Two South China Sea Nudibranchs Phyllidiella pustulosa, Phyllidia coelestis, and Their Sponge-Prey Acanthella cavernosa. Marine Drugs. 17(1). 56–56. 32 indexed citations
7.
Wu, Qihao, Xu‐Wen Li, Heng Li, et al.. (2018). Bioactive polyoxygenated cembranoids from a novel Hainan chemotype of the soft coral Sinularia flexibilis. Bioorganic & Medicinal Chemistry Letters. 29(2). 185–188. 32 indexed citations
8.
Hu, Jianping, Ying-Qing Wang, Yanlian Li, et al.. (2017). Discovery of a series of dihydroquinoxalin-2(1H)-ones as selective BET inhibitors from a dual PLK1-BRD4 inhibitor. European Journal of Medicinal Chemistry. 137. 176–195. 30 indexed citations
9.
Yi, Jun-Mei, Xia‐Juan Huan, Shanshan Song, et al.. (2016). Triptolide Induces Cell Killing in Multidrug-Resistant Tumor Cells via CDK7/RPB1 Rather than XPB or p44. Molecular Cancer Therapeutics. 15(7). 1495–1503. 32 indexed citations
10.
11.
Wang, Wei, Ying-Qing Wang, Tao Meng, et al.. (2014). MCL-1 Degradation Mediated by JNK Activation via MEKK1/TAK1-MKK4 Contributes to Anticancer Activity of New Tubulin Inhibitor MT189. Molecular Cancer Therapeutics. 13(6). 1480–1491. 29 indexed citations
12.
Manzo, Stefano Giustino, Zhaoli Zhou, Ying-Qing Wang, et al.. (2012). Natural Product Triptolide Mediates Cancer Cell Death by Triggering CDK7-Dependent Degradation of RNA Polymerase II. Cancer Research. 72(20). 5363–5373. 94 indexed citations
13.
Yu, Bing, Ze‐Hong Miao, Yi Jiang, et al.. (2009). c-Jun Protects Hypoxia-Inducible Factor-1α from Degradation via Its Oxygen-Dependent Degradation Domain in a Nontranscriptional Manner. Cancer Research. 69(19). 7704–7712. 42 indexed citations
14.
Sun, Qiming, Ze‐Hong Miao, Liping Lin, et al.. (2009). BB, a new EGFR inhibitor, exhibits prominent anti-angiogenesis and antitumor activities. Cancer Biology & Therapy. 8(17). 1640–1647. 10 indexed citations
15.
Huang, Min, Ze‐Hong Miao, Hong Zhu, et al.. (2008). Chk1 and Chk2 are differentially involved in homologous recombination repair and cell cycle arrest in response to DNA double-strand breaks induced by camptothecins. Molecular Cancer Therapeutics. 7(6). 1440–1449. 62 indexed citations
16.
Meng, Ling‐Hua, Zhaojing Meng, Ze‐Hong Miao, Timothy D. Veenstra, & Yves Pommier. (2008). Cytokeratin-RNA Cross-Linking Mediated by the Antitumor Aminoflavone, 5-Amino-2,3-fluorophenyl-6,8-difluoro-7-methyl-4 H-1-benzopyran-4-one. Journal of Pharmacology and Experimental Therapeutics. 325(2). 674–680. 12 indexed citations
17.
Pommier, Yves, Smitha Antony, Ze‐Hong Miao, et al.. (2007). Novel indenoisoquinolines NSC 725776 and NSC 724998 produce persistent topoisomerase I cleavage complexes and overcome multidrug resistance. Molecular Cancer Therapeutics. 6. 1 indexed citations
18.
Antony, Smitha, Keli Agama, Ze‐Hong Miao, et al.. (2007). Novel Indenoisoquinolines NSC 725776 and NSC 724998 Produce Persistent Topoisomerase I Cleavage Complexes and Overcome Multidrug Resistance. Cancer Research. 67(21). 10397–10405. 113 indexed citations
19.
Rao, V. Ashutosh, Chiara Conti, Josée Guirouilh‐Barbat, et al.. (2007). Endogenous γ-H2AX-ATM-Chk2 Checkpoint Activation in Bloom's Syndrome Helicase–Deficient Cells Is Related to DNA Replication Arrested Forks. Molecular Cancer Research. 5(7). 713–724. 76 indexed citations
20.
Miao, Ze‐Hong, et al.. (2007). ATM, ATR and DNA damage-induced cell cycle arrest. Shengming kexue. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maciej Czerwiński Breakdown of academic impact, for papers by Shiow‐Lin Pan Breakdown of academic impact, for papers by Michael C. Alley Breakdown of academic impact, for papers by Yongkui Jing Breakdown of academic impact, for papers by Zhi Shi Breakdown of academic impact, for papers by Curtis Hose Breakdown of academic impact, for papers by Jiang‐Jiang Qin Breakdown of academic impact, for papers by Betty J. Abbott Breakdown of academic impact, for papers by Chunlin Zhuang Breakdown of academic impact, for papers by Chakrabhavi Dhananjaya Mohan
Rankless by CCL
2026